Scientific and Medical Equipment House Company
4014.SRSAUHealthcare● Active
$31.50
$-0.10(-0.32%)
Market Cap$945000000
P/E Ratio—
52W High$41
52W Low$26
Scientific and Medical Equipment House Company（4014.SR）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · 4014.SR · 截至 2026-06-15
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.03B | $0.04B | $0.05B | $0.02B | $0.08B |
| Depreciation & Amort. | $0.02B | $0.02B | $0.02B | $0.01B | $0.01B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.07B) | $0.20B | ($0.26B) | $0.03B | ($0.19B) |
| Net Cash from Operations | ($0.01B) | $0.29B | ($0.14B) | $0.12B | ($0.08B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.00B) | ($0.01B) | ($0.02B) | ($0.01B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| Net Cash from Investing | ($0.01B) | ($0.00B) | ($0.01B) | ($0.02B) | $0.00B |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.03B) | ($0.03B) | $0.00B | ($0.02B) | ($0.03B) |
| Debt Issued / Repaid | ($0.02B) | ($0.15B) | $0.15B | ($0.07B) | $0.07B |
| Net Cash from Financing | ($0.05B) | ($0.21B) | $0.12B | ($0.10B) | $0.04B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.01B) | $0.29B | ($0.16B) | $0.11B | ($0.09B) |
| FCF Margin %(computed) | -1.46% | 32.58% | -19.46% | 14.88% | -13.18% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-15 · SAR · B
深入了解Scientific and Medical Equipment House Company
关于Scientific and Medical Equipment House Company（4014.SR）现金流量表
Scientific and Medical Equipment House Company 2025财年经营活动现金流($0.01B)，自由现金流($0.01B)（FCF利润率-1.46%），资本支出($0.01B)。
常见问题
4014.SR · 4 问Scientific and Medical Equipment House Company 2025财年自由现金流($0.01B)，同比down104.5%。
4014.SR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15